We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

JUN 27 2018

FDA Approval of GW Pharma's Cannabis-Based Drug Marks Milestone - The Street

Will Garvin, Shareholder in the firm's FDA & Biotechnology practice, comments on the impact of the FDA's recent approval of an epilepsy drug, Epidiolex, the Administration's first approved medical use of cannabidiol in The Street's "FDA Approval of GW Pharma's Cannabis-Based Drug Marks Milestone."